Surveillance of authorised veterinary medicines

Once a veterinary medicine has been approved by authorities, the medical company is issued a so-called marketing authorisation. Now the medicine can be sold and used in animals in all or parts of Europe. Sometimes, veterinary medicines may also be separately approved in other parts of the world.

Even after authorisation both the marketing authorisation holder (the medical company) and the authorities are obligated to continue to monitor the safety and efficacy of the veterinary medicinal product. Surveillance of medicines is called ’pharmacovigilance’.